These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Detection of hepatitis C virus in patients with terminal renal disease undergoing dialysis in southern Brazil: prevalence, risk factors, genotypes, and viral load dynamics in hemodialysis patients. Vidales-Braz BM; da Silva NM; Lobato R; Germano FN; da Mota LD; Barros EJ; de Martinez AM Virol J; 2015 Feb; 12():8. PubMed ID: 25644891 [TBL] [Abstract][Full Text] [Related]
4. Distribution of HCV genotypes in patients with end-stage renal disease according to type of dialysis treatment. Selcuk H; Kanbay M; Korkmaz M; Gur G; Akcay A; Arslan H; Ozdemir N; Yilmaz U; Boyacioglu S Dig Dis Sci; 2006 Aug; 51(8):1420-5. PubMed ID: 16868830 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis C infection in dialysis patients in Israel. Weinstein T; Tur-Kaspa R; Chagnac A; Korzets A; Ori Y; Zevin D; Herman M; Gafter U Isr Med Assoc J; 2001 Mar; 3(3):174-7. PubMed ID: 11303373 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus infections in dialysis centers in The Netherlands: a national survey by serological and molecular methods. Schneeberger PM; Keur I; van der Vliet W; van Hoek K; Boswijk H; van Loon AM; van Dijk WC; Kauffmann RH; Quint W; van Doorn LJ J Clin Microbiol; 1998 Jun; 36(6):1711-5. PubMed ID: 9620405 [TBL] [Abstract][Full Text] [Related]
7. [Viral hepatitis C in patients with terminal chronic renal insufficiency. III. Viral quantification]. González-Michaca L; Soto-Ramírez LE; Rodríguez R; Gamba G Rev Invest Clin; 2001; 53(1):21-7. PubMed ID: 11332047 [TBL] [Abstract][Full Text] [Related]
8. [Viral C hepatitis in patients with end stage renal disease. II. Viral genotypes]. González-Michaca L; Mercado A; Gamba G Rev Invest Clin; 2000; 52(5):491-6. PubMed ID: 11195176 [TBL] [Abstract][Full Text] [Related]
9. Type-specific antibody for hepatitis C virus detected by use of NS-4 peptide and hepatitis C virus genome in Korea. Son HC; Yoon MS; Kim YJ; Kim IH; Kim YS Rinsho Byori; 2002 May; 50(5):533-40. PubMed ID: 12078055 [TBL] [Abstract][Full Text] [Related]
10. [The presence of hepatitis C virus (HCV) infection in hemodialysis patients and determination of HCV genotype distribution]. Bozdayi G; Rota S; Verdi H; Derici U; Sindel S; Bali M; Başay T Mikrobiyol Bul; 2002; 36(3-4):291-300. PubMed ID: 12838663 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of a total core antigen assay for the diagnosis of hepatitis C virus infection in hemodialysis patients. Bouzgarrou N; Fodha I; Othman SB; Achour A; Grattard F; Trabelsi A; Pozzetto B J Med Virol; 2005 Dec; 77(4):502-8. PubMed ID: 16254976 [TBL] [Abstract][Full Text] [Related]
12. [Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients]. Dağlar D; Ergani A; Demirbakan H; Ozhak Baysan B; Ongüt G; Koçak H; Oğünç D; Akbaş H; Yıldırım B; Colak D Mikrobiyol Bul; 2014 Jan; 48(1):143-50. PubMed ID: 24506725 [TBL] [Abstract][Full Text] [Related]
13. Molecular evidence for nosocomial spread of two different hepatitis C virus strains in one hemodialysis unit. Seme K; Poljak M; Zuzec-Resek S; Debeljak M; Dovc P; Koren S Nephron; 1997; 77(3):273-8. PubMed ID: 9375819 [TBL] [Abstract][Full Text] [Related]
14. Serotyping strip immunoblot assay for assessing hepatitis C virus strains in dialysis patients. Fabrizi F; Martin P; Quan S; Dixit V; Brezina M; Conrad A; Polito A; Gitnick G Am J Kidney Dis; 2000 May; 35(5):832-8. PubMed ID: 10793016 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus molecular epidemiology in Uzbekistan. Kurbanov F; Tanaka Y; Sugauchi F; Kato H; Ruzibakiev R; Zalyalieva M; Yunusova Z; Mizokami M J Med Virol; 2003 Mar; 69(3):367-75. PubMed ID: 12526047 [TBL] [Abstract][Full Text] [Related]
16. Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group. Lau JY; Davis GL; Prescott LE; Maertens G; Lindsay KL; Qian K; Mizokami M; Simmonds P Ann Intern Med; 1996 May; 124(10):868-76. PubMed ID: 8610915 [TBL] [Abstract][Full Text] [Related]
17. Virological and histological features of hepatitis C virus (HCV) infection in kidney transplant recipients. Fabrizi F; Lunghi G; Marai P; Marcelli D; Guarnori I; Raffaele L; Erba G; Pagano A; Locatelli F Nephrol Dial Transplant; 1996 Jan; 11(1):159-64. PubMed ID: 8649626 [TBL] [Abstract][Full Text] [Related]
18. Serotyping of hepatitis C virus in hemodialysis patients: comparison with a standardized genotyping assay. Elsawy EM; Sobh MA; El-Chenawi FA; Hassan IM; Shehab El-Din AB; Ghoneim MA Diagn Microbiol Infect Dis; 2005 Feb; 51(2):91-4. PubMed ID: 15698713 [TBL] [Abstract][Full Text] [Related]
19. Virological characteristics of hepatitis C virus infection in chronic hemodialysis patients: a cross-sectional study. Fabrizi F; Lunghi G; Guarnori I; Raffaele L; Di Filippo S; Erba G; Pagano A; Locatelli F Clin Nephrol; 1995 Jul; 44(1):49-55. PubMed ID: 7554533 [TBL] [Abstract][Full Text] [Related]
20. Maintenance hemodialysis decreases serum hepatitis C virus (HCV) RNA levels in hemodialysis patients with chronic HCV infection. Furusyo N; Hayashi J; Ariyama I; Sawayama Y; Etoh Y; Shigematsu M; Kashiwagi S Am J Gastroenterol; 2000 Feb; 95(2):490-6. PubMed ID: 10685756 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]